Document is current
Any future updates will be listed below
-
Authors
Hsu, Chia-Chi
Huang, Derek De-Rui
Hsu, Wei-Hsun
Hsieh, Min-Shu
Lin, Fang-Yu
Tai, Pei-Chen
Chou, Shih-Yun
Tsai, Hsin-Hui
Tseng, Chen-Yuan
Liao, Bin-Chi
Shih, Jin-Yuan
Yang, James Chih-Hsin
-
Funding
Funding for this research was provided by:
National Taiwan University Cancer Center (NTUCCS-113-05)
National Science and Technology Council (111-2811-B-002-058)
Ministry of Education (112L901403)
- License Information
-
More Information
Article History
Received: 30 July 2025
Accepted: 29 August 2025
First Online: 9 October 2025
Declarations
:
: All animal experiments were conducted in accordance with institutional guidelines and were approved by the Institutional Animal Care and Use Committee (IACUC) of National Taiwan University College of Medicine.
: Not applicable.
: Dr. Yang reports personal and/or institutional fees from Amgen, grants and personal and institutional fees from AstraZeneca, institutional fees from Bayer, personal and institutional fees from Boehringer Ingelheim, personal fees from Bristol Myers Squibb, institutional fees from Daiichi Sankyo, institutional fees from Eli Lilly, institutional fees from Merck KGaA, Darmstadt, Germany, institutional fees from Merck Sharp & Dohme, personal and institutional fees from Novartis, personal fees from Ono Pharmaceuticals, personal fees from Pfizer, personal and institutional fees from Roche/Genentech, personal and institutional fees from Takeda Oncology, personal and institutional fees from Yuhan Pharmaceuticals, institutional fee from JNJ, outside the submitted work. No potential conflicts of interest were disclosed by the other authors.
